A class 2 medicines recall has been issued for all unexpired stock of Motilium 10 and Motilium Instants (domperidone; McNeil). This is due to a decision by the UK Commission on Human Medicines that domperidone no longer meets the requirements of pharmacy “P” medicine. Pharmacists and wholesalers will be contacted by Johnson and Johnson, which is recalling the medicine on behalf of the marketing authorisation holder. Further information on 0808 238 978.
http://www.pharmaceutical-journal.com/news-and-analysis/notice-board/motilium-drug-recall/20066339.article
No comments:
Post a Comment